Loading company…
Ningbo-based medical company focused on precision medicine, early cancer detection and diagnostic and prognostic biomarkers.
Established in 2016 and based in Ningbo, China, My-Biomed Biotechnology Co., Ltd works on precision medicine development, early cancer detection, and diagnostic and prognostic biomarkers. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in